An innovative drug could slash the risk of muscle loss for patients on weight loss, a new study has suggested.

A major new study looks at thousands of people taking the medication

Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines

An innovative drug could slash the risk of muscle loss for patients on weight loss, a new study has suggested.

An experimental daily weight loss pill helped people shift more than ten per cent of their bodyweight after six months, research has found.

A new drug promoting muscle growth may help counteract the significant lean body mass loss—up to 40%—associated with GLP-1-based slimming jabs like Wegovy and Mounjaro.